Nanoguardmed
1 known investors
NanoGuard Technologies develops cold plasma (HVACP) technology for sterilization applications in the agricultural and medical industries, achieving a 6.0-log reduction of Bacillus atrophaeus spore strips as an alternative to ethylene oxide sterilization. The company holds four global patents for its HVACP technology across 28 countries.
AgTechDeep TechMedical Devices
Investors · 1
Frequently asked questions
- What does Nanoguardmed do?
- NanoGuard Technologies develops cold plasma (HVACP) technology for sterilization applications in the agricultural and medical industries, achieving a 6.0-log reduction of Bacillus atrophaeus spore strips as an alternative to ethylene oxide sterilization. The company holds four global patents for its HVACP technology across 28 countries.
- Who are Nanoguardmed's investors?
- Nanoguardmed's investors include Fulcrum Global Capital.